Is 88 mcg of Levothyroxine a High Dose?

For most adults, 88 mcg of levothyroxine falls squarely in the low-to-middle range of prescribed doses, not anywhere near the high end. Standard tablets come in strengths from 25 mcg all the way up to 300 mcg, and 88 mcg sits closer to the bottom third of that range. But whether any particular dose is “right” depends almost entirely on your body weight, age, what caused your hypothyroidism, and how well your gut absorbs the drug. Those variables matter far more than the number printed on the pill.

Where 88 mcg Falls on the Dosing Spectrum

Levothyroxine tablets are manufactured in a wide range of strengths: 25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200, and 300 mcg.¹ When doctors prescribe levothyroxine, they typically calculate a target based on your body weight and then round to the nearest available tablet. The textbook starting point for full thyroid replacement in a younger adult is about 1.6 mcg per kilogram of body weight per day. At that rate, 88 mcg would be the calculated dose for someone weighing roughly 55 kg, or about 121 pounds. If you weigh significantly more than that, 88 mcg is a relatively modest dose. If you weigh less, it might be on the higher side of what your body needs.

In practice, though, most people end up on less than that textbook figure. A study drawing from the Baltimore Longitudinal Study of Aging found that participants with normal thyroid levels were taking an average of about 1.09 mcg per kilogram, and a full 84% were well-controlled on less than the traditional 1.6 mcg/kg recommendation.² That means for a 75 kg (165 lb) person, an effective dose might be closer to 82 mcg rather than 120 mcg. In that context, 88 mcg could be close to a full replacement dose for a person of average weight, not just a low starter amount.

Why the Same Dose Can Be Too Much for One Person and Too Little for Another

Body weight is only part of the equation. The cause of your hypothyroidism has a surprisingly large effect on how much levothyroxine you need. People treated for thyroid cancer who have had their thyroid completely removed tend to require higher doses, around 2.11 mcg/kg/day, because there is no remaining thyroid tissue contributing any hormone at all. By contrast, people with hypothyroidism from non-cancerous causes needed significantly less, averaging about 1.63 mcg/kg/day.³ That gap exists because most people with Hashimoto’s thyroiditis or post-radioiodine hypothyroidism still have some residual thyroid tissue producing a trickle of hormone on its own. That trickle matters: it effectively reduces the amount of levothyroxine your prescription needs to supply.

The same research found an interesting wrinkle. Among people with benign hypothyroidism, those who developed it after radioactive iodine treatment for Graves’ disease needed even lower doses than those with spontaneous hypothyroidism. The likely explanation is that thyroid-stimulating antibodies, which caused the Graves’ disease in the first place, can persist and continue prodding whatever thyroid remnant is left to produce some hormone. So a person with post-Graves’ hypothyroidism might do well on 75 mcg while someone of identical weight with Hashimoto’s might need 100 mcg. There is no universal “high” or “low” without knowing what is going on under the hood.

Age, Obesity, and Other Variables That Shift the Target

Older adults consistently need lower doses per kilogram than younger ones. The Baltimore study found that dose-per-weight estimates for thyroid replacement in older adults were roughly one-third lower than the standard recommendations developed for younger populations. Among the older adults studied, obese participants (those with a BMI of 30 or above) reached normal thyroid levels at an even lower weight-based ratio, about 0.90 mcg/kg, compared to 1.14 mcg/kg for non-obese participants.² This means an older adult weighing 90 kg might be perfectly well-managed on 81 mcg or so, making 88 mcg a comfortable fit without being “high” at all.

The obesity piece can confuse patients. If you weigh 100 kg and your doctor prescribes 88 mcg, you might think the dose sounds low compared to the 160 mcg that the textbook 1.6 mcg/kg formula would suggest. But because fat tissue does not drive thyroid hormone requirements the way lean tissue does, the effective calculation should use a lower multiplier or lean body weight instead. Interestingly, when the Baltimore researchers recalculated doses using ideal body weight rather than actual weight, the difference between obese and non-obese participants disappeared.

Predicting the right dose is genuinely difficult. One large retrospective study of nearly 600 patients who had total thyroidectomy for benign disease compared multiple dosing formulas and found that even the best statistical model correctly predicted only about 65% of patients’ eventual stable doses. The standard 1.6 mcg/kg rule got it right barely half the time.⁴ That is why levothyroxine dosing is less about hitting a number on day one and more about starting somewhere reasonable and adjusting based on blood work.

Pregnancy Changes Everything

If you are pregnant or planning to become pregnant, 88 mcg may not stay adequate. Pregnancy dramatically increases the body’s demand for thyroid hormone. One study found that levothyroxine requirements jumped by an average of 47% during the first half of pregnancy, with the increase typically beginning around eight weeks of gestation and plateauing by week 16.⁵ A woman stable on 88 mcg before pregnancy could easily need 125 or 137 mcg during pregnancy.

A longitudinal study confirmed the scope of this shift: roughly 84% of pregnant women with hypothyroidism required a dose increase, with the average requirement climbing by about 50% in the first trimester and continuing to rise through delivery.⁶ This is not a sign that 88 mcg was ever wrong; the physiology of pregnancy simply places much larger demands on the thyroid system. After delivery, most women return to their pre-pregnancy dose.

When Absorption Problems Make Any Dose Feel Inadequate

Sometimes the issue is not the number on the pill but how much of it actually reaches your bloodstream. Levothyroxine is absorbed in the small intestine, and anything that disrupts the lining or chemistry of that area can reduce how much gets through. Celiac disease, for instance, can significantly impair levothyroxine absorption even when the prescribed dose seems appropriate.⁷ A gluten-free diet often helps, but some patients continue to need higher doses to compensate.

A study of patients with so-called “refractory hypothyroidism,” where TSH stays stubbornly elevated despite seemingly adequate doses, found that the most common culprits were gastritis (24% of cases), Helicobacter pylori infection (18%), and drug interactions that block absorption (about 16%). Nonadherence to treatment accounted for another 10%.⁸ Bariatric surgery and celiac disease were less frequent causes but still real ones. In these situations, a patient on 88 mcg might have the TSH levels of someone taking 50 mcg because the drug simply is not getting absorbed.

Food and supplements cause their own interference. A systematic review found that coffee, soy products, fiber, and calcium or iron supplements all reduced levothyroxine absorption.⁹ Calcium is a particularly well-studied offender. One trial showed that taking calcium carbonate alongside levothyroxine cut absorption by roughly 20–25%, enough that a fifth of patients developed TSH levels above the normal range.¹⁰ ¹¹ The standard advice to take levothyroxine on an empty stomach, at least 30 to 60 minutes before food and well separated from supplements, exists for good reason. If you have been lax about timing and your TSH keeps creeping up, fixing the timing might work better than increasing the dose.

Risks of Taking More Than You Need

The reason doctors are cautious about levothyroxine doses is that the drug has a narrow therapeutic index, meaning there is not much room between an effective dose and one that causes harm. Multiple regulatory agencies worldwide, including the FDA and Health Canada, classify levothyroxine as a narrow therapeutic index drug and apply stricter manufacturing standards to it as a result.¹²

Excessive levothyroxine, which pushes TSH below normal and creates a state of subclinical or overt hyperthyroidism, poses two well-documented risks. The first is cardiac arrhythmia, especially atrial fibrillation. A review of the evidence found that levothyroxine therapy lowers the threshold for arrhythmias, and the risk rises when clinicians push doses higher to achieve TSH values at the very low end of normal.¹³ A large nested case-control study quantified this: patients with high levothyroxine exposure had about 29% higher odds of developing atrial fibrillation compared to those with low exposure.¹⁴

The second major concern is bone loss. In elderly women with osteoporosis, those taking more than 150 mcg per day had roughly 56% higher fracture risk compared to those in the 51–100 mcg range. When the analysis was restricted to women also taking osteoporosis-specific drugs (a strong indicator of confirmed osteoporosis), fracture risk was nearly double.¹⁵ These risks are associated with doses well above 88 mcg and with suppressed TSH levels, but they illustrate why “more is better” is emphatically not the right mindset with this drug.

What Happens When the Dose Is Too Low

On the other side of the equation, staying on an inadequate dose leaves hypothyroidism partially untreated. Beyond the familiar symptoms of fatigue and cold intolerance, undertreated hypothyroidism has measurable metabolic effects. One study tracked patients before and after levothyroxine brought their TSH into the normal range and found that total cholesterol dropped from about 204 to 167, and LDL cholesterol fell from roughly 124 to 96.¹⁶ Triglycerides also improved, dropping from about 146 to 122. These are not trivial differences. Persistently elevated cholesterol from an inadequately treated thyroid can contribute to cardiovascular risk over time, and it sometimes gets misattributed to diet or genetics when the real fix is a dose adjustment.

How Doctors Know the Dose Is Working

Levothyroxine has a half-life of about a week, which means it takes roughly six weeks of consistent daily use before blood levels stabilize. That is why your doctor waits at least six weeks after any dose change before rechecking your TSH.¹⁷ If the TSH is not at the target, the dose gets nudged up or down, often by just one tablet strength (for example, from 88 to 100 mcg, or down from 88 to 75 mcg). This gradual titration is how thyroid management actually works in practice. You land on 88 mcg not because of a formula, but because your blood tests told your doctor it was the right place to be, or close to it.

Worth knowing: once your dose is stable and your TSH is in the target range, ongoing monitoring typically happens every six to twelve months. Life events that should trigger an earlier recheck include significant weight change, starting or stopping estrogen therapy, pregnancy, or beginning any new medication known to interfere with thyroid hormone absorption or metabolism.

Why Switching Brands or Generics Can Unsettle a Stable Dose

Because levothyroxine has such a narrow therapeutic window, small differences between manufacturers can sometimes matter. A study comparing the dissolution profiles of four different levothyroxine formulations found that they dissolved at different rates depending on the pH of the surrounding fluid, and these differences could affect how much drug gets absorbed.¹⁸ In theory, switching from one manufacturer’s 88 mcg tablet to another’s could shift how much active hormone you actually absorb.

In practice, though, a large propensity-matched study of nearly 2,800 patient pairs found that switching from one generic levothyroxine to another did not cause clinically meaningful changes in TSH levels. About 83% of nonswitchers and 85% of switchers maintained normal TSH values, and the rates of markedly abnormal levels were virtually identical between groups.¹⁹ So while the theoretical concern is real, the real-world impact for most people seems to be small. That said, if you have been stable for years and suddenly your TSH shifts after a pharmacy switch, the change in manufacturer is worth mentioning to your doctor.

Morning Versus Bedtime Dosing

Most people take levothyroxine first thing in the morning on an empty stomach, but there has been genuine research interest in whether bedtime dosing might work just as well or even better. One randomized crossover trial found that bedtime dosing actually produced lower TSH levels and slightly higher free T4 levels than morning dosing, with TSH dropping by about 1.25 mIU/L on average when the same patients switched to nighttime.²⁰ The likely explanation is that an overnight fast provides a longer, more reliable empty-stomach window than the often-rushed morning routine.

However, a trial specifically in older patients found no statistically significant difference in TSH between morning and bedtime dosing.²¹ The practical takeaway is that either timing can work. If you struggle to maintain the empty-stomach window in the morning because of other medications or an early breakfast, bedtime dosing is a reasonable alternative to discuss with your doctor. The key point for someone on 88 mcg is that consistent timing matters more than which time you pick.

When You Still Feel Bad Despite Normal Blood Work

A frustrating reality of levothyroxine therapy is that a substantial number of patients continue to experience symptoms even when their TSH has reached the normal range. This is not in anyone’s head. A narrative review described it as a recognized phenomenon: a significant minority of patients report persistent symptoms such as fatigue, brain fog, and weight issues despite normal thyroid biochemistry on levothyroxine.²²

A prospective study put numbers to the problem. At each follow-up period after starting levothyroxine, roughly 27–28% of patients with normal TSH levels had either persistent or newly developed symptoms, with fatigue being the most consistently reported.²³ For someone on 88 mcg who feels lousy despite “perfect” lab results, this is worth understanding. The problem is not necessarily that 88 mcg is too low or too high. It may reflect the limitations of TSH as a sole marker, the possibility of coexisting conditions (iron deficiency, vitamin B12 deficiency, and sleep disorders are common culprits), or individual variation in how the body converts T4 to the more active T3 hormone. Bumping the dose to chase symptom relief when TSH is already normal risks the cardiac and bone consequences described earlier, so the better path is usually a broader investigation of what else might be contributing.